Brief: Enorama Pharma Extends Period For Trading In Subscription Rights In Ongoing Rights Issue
Feb 21(Reuters) - Norama Pharma AB ERMA.ST :
* SAID ON THURSDAY HAS DECIDED TO EXTEND THE PERIOD FOR
TRADING IN
SUBSCRIPTION RIGHTS UNTIL MARCH 3, 2025
Source text for Workspace: urn:newsml:reuters.com:*:nWkr2gdrSF
Further company coverage: ERMA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO